Pre- and post-treatment biomarkers for non-small cell lung cancer treated with immune checkpoint inhibitor

被引：0
|
作者：
Murata, D. [1 ]
Azuma, K. [1 ]
Nishii, Y. [1 ]
Tokito, T. [1 ]
Hoshino, T. [1 ]
机构：
[1] Kurume Univ, Sch Med, Div Respirol Neurol & Rheumatol, Kurume Univ Hosp, Kurume, Fukuoka, Japan
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.07.533
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MO10-1
引用
收藏
页码：S1333 / S1333
页数：1
相关论文
共 50 条
  • [1] Modifiable biomarkers of response to immune checkpoint inhibitor treatment in non-small cell lung cancer
    Spakowicz, D.
    Williams, N.
    Bibi, A.
    Hoyd, R.
    Wheeler, C. E.
    Suman, S.
    Amann, J.
    Okimoto, T.
    Grogan, M.
    Vibhakar, P.
    Owen, D.
    Carbone, D. P.
    Presley, C.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S345 - S346
  • [2] Identification of Biomarkers for Non-small-cell Lung Cancer Patients Treated With an Immune Checkpoint Inhibitor
    Kubo, Sousuke
    Kobayashi, Nobuaki
    Somekawa, Kohei
    Hirata, Momo
    Kamimaki, Chisato
    Aiko, Hiroko
    Katakura, Seigo
    Teranishi, Shuhei
    Watanabe, Keisuke
    Hara, Yu
    Yamamoto, Masaki
    Kudo, Makoto
    Kaneko, Takeshi
    ANTICANCER RESEARCH, 2020, 40 (07) : 3889 - 3896
  • [3] Using cell-free DNA to predict response to immunotherapy in non-small cell lung cancer pre- and post-treatment
    Rao, Satyanarayan
    Zukowski, Alexis
    Weirich, Abigail
    Kabos, Peter
    Stensland, Elin Marie
    Eide, Inger Johanne Zwicky
    Brustugun, Odd Terje
    Ramachandran, Srinivas
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Pre- and post-treatment PET/CT to evaluate the response of non-small cell lung cancer (NSCLC) treated with curative radiotherapy alone (RT)
    Faria, S.
    Lisbona, R.
    Stern, J.
    Souhami, L.
    Portelance, L.
    Devic, S.
    Freeman, C.
    RADIOTHERAPY AND ONCOLOGY, 2006, 80 : S50 - S50
  • [5] Biomarkers for immune checkpoint inhibition in non-small cell lung cancer (NSCLC)
    Bodor, J. Nicholas
    Boumber, Yanis
    Borghaei, Hossein
    CANCER, 2020, 126 (02) : 260 - 270
  • [6] Imaging of Immune Checkpoint Inhibitor Immunotherapy for Non-Small Cell Lung Cancer
    Shroff, Girish S.
    Strange, Chad D.
    Ahuja, Jitesh
    Altan, Mehmet
    Sheshadri, Ajay
    Unlu, Ebru
    Truong, Mylene T.
    Vlahos, Ioannis
    RADIOGRAPHICS, 2022, 42 (07) : 1956 - 1974
  • [7] Angiogenesis and Immune-Related Biomarkers in Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors
    Grapsa, D.
    Papadopoulou, A.
    Kokkotou, E.
    Gaitanakis, S.
    Gkiozos, I.
    Charpidou, A.
    Syrigos, K.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S331 - S332
  • [8] Exploring histological predictive biomarkers for immune checkpoint inhibitor therapy response in non-small cell lung cancer
    Cho, Uiju
    Im, Soyoung
    Park, Hyung Soon
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2024, 58 (02) : 49 - 58
  • [9] Radiomics Biomarkers to Predict Checkpoint Inhibitor Pneumonitis in Non-small Cell Lung Cancer
    Du, Yonghao
    Zhang, Shuo
    Jia, Xiaohui
    Zhang, Xi
    Li, Xuqi
    Pan, Libo
    Li, Zhihao
    Niu, Gang
    Liang, Ting
    Guo, Hui
    ACADEMIC RADIOLOGY, 2025, 32 (03) : 1685 - 1695
  • [10] The Impact of Inflammatory Serum Biomarkers in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors
    Cipriano, E.
    Magalhaes, H.
    Estevinho, F.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S255 - S255
12345